Executive Committee:
- Gordon McCauley, President and CEO, adMare BioInnovations (Chair)
- Roberto Bellini, President & CEO, Bellus Health (Vice Chair)
- Oliver Technow, CEO, BioVectra Inc. (Treasurer)
- Andrew Casey, President & CEO, BIOTECanada (Secretary)
Directors:
- Norma Biln, CEO, Augurex
- Neal Carter, President & Founder, Okanagan Specialty Fruits
- Andy Haigh, President and CEO, Adapsyn Bioscience
- Alok Kanti, General Manager, Bayer Canada
- Melissa Koomey, Vice President & General Manager, Gilead Sciences Canada
- A.J. (Sandy) Marshall, Chairman, Bioindustrial Innovation Canada
- Jeffrey Miller, General Manager, Alnylam Pharmaceuticals Canada
- John Norman, Partner, Gowling WLG (Canada) LLP
- Frederic Ors, CEO, IMV Inc.
- Tracey Ramsay, Vice President and General Manager, AbbVie Canada
- Alan Reba, General Manager, Bristol-Myers Squibb
- Sanj Singh, President & CEO, Temple Therapeutics B.V.
- Jamie Stiff, Managing Director, Genesys Capital
- Ali Tehrani, President and CEO, Zymeworks Inc.
- Shermaine Tilley, Managing Partner, CTI Life Sciences Fund
